Cencora Inc

More Details of Cencora Inc Company

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Company Info

Company codeCOR

Company nameCencora Inc

IPO dateMay 28, 1996

Founded at2001

CEODr. Robert P. (Bob) Mauch, Ph.D.

Number of employees42000

Security typeOrdinary Share

Fiscal year-endMay 28

Address1 West First Avenue

CityCONSHOHOCKEN

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code19428

Phone16107277000

Websitehttps://www.cencora.com/

Company codeCOR

IPO dateMay 28, 1996

Founded at2001

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

317.91K

-0.63%

Mr. Lon R. Greenberg

Independent Director

22.11K

+3.70%

Ms. Silvana Battaglia

Chief Human Resource Officer, Executive Vice President

15.37K

-24.54%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.66K

-21.96%

Mr. Dennis M. Nally

Independent Director

12.29K

+6.86%

Mr. Werner Baumann

Independent Director

2.77K

+39.81%

Dr. Lorence H. Kim, M.D.

Independent Director

957.00

+469.64%

Mr. Bennett S. Murphy

Senior Vice President, Investor Relations

--

Mr. Francois Mandeville

Executive Vice President - Strategy and M&A

--

Mr. D. Mark Durcan

Lead Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

317.91K

-0.63%

Mr. Lon R. Greenberg

Independent Director

22.11K

+3.70%

Ms. Silvana Battaglia

Chief Human Resource Officer, Executive Vice President

15.37K

-24.54%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.66K

-21.96%

Mr. Dennis M. Nally

Independent Director

12.29K

+6.86%

Mr. Werner Baumann

Independent Director

2.77K

+39.81%

Revenue Breakdown

No Data

No Data

By Business

By Region

No Data

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

10.96%

BlackRock Institutional Trust Company, N.A.

5.56%

Walgreens Boots Alliance Inc

5.36%

T. Rowe Price Associates, Inc.

4.44%

State Street Global Advisors (US)

4.15%

Other

69.53%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

10.96%

BlackRock Institutional Trust Company, N.A.

5.56%

Walgreens Boots Alliance Inc

5.36%

T. Rowe Price Associates, Inc.

4.44%

State Street Global Advisors (US)

4.15%

Other

69.53%

Type

Shareholder

Proportion

Investment Advisor

40.06%

Investment Advisor/Hedge Fund

38.08%

Corporation

5.36%

Research Firm

4.19%

Hedge Fund

3.92%

Pension Fund

2.08%

Bank and Trust

1.95%

Sovereign Wealth Fund

1.19%

Family Office

1.17%

Other

1.99%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2167

189.96M

98.06%

-8.34M

2024Q4

2214

199.54M

103.03%

-6.12M

2024Q3

2134

200.05M

102.56%

+474.02K

2024Q2

2090

200.10M

100.34%

-7.14M

2024Q1

2068

201.37M

100.95%

-1.37M

2023Q4

1982

202.46M

101.40%

+179.01K

2023Q3

1885

197.70M

97.79%

-2.16M

2023Q2

1870

195.01M

96.41%

-1.88M

2023Q1

1823

192.70M

95.24%

-7.51M

2022Q4

1797

190.05M

93.86%

-247.07K

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

21.22M

10.96%

+5.67K

+0.03%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

10.77M

5.56%

+112.08K

+1.05%

Dec 31, 2024

Walgreens Boots Alliance Inc

10.38M

5.36%

-2.19M

-17.42%

Mar 21, 2025

T. Rowe Price Associates, Inc.

8.61M

4.44%

+71.27K

+0.84%

Dec 31, 2024

State Street Global Advisors (US)

8.03M

4.15%

-14.00K

-0.17%

Dec 31, 2024

Wellington Management Company, LLP

5.06M

2.61%

-135.53K

-2.61%

Dec 31, 2024

Boston Partners

5.01M

2.58%

+125.61K

+2.57%

Dec 31, 2024

Geode Capital Management, L.L.C.

4.33M

2.23%

+130.21K

+3.10%

Dec 31, 2024

JP Morgan Asset Management

3.45M

1.78%

+46.78K

+1.37%

Dec 31, 2024

Capital Research Global Investors

2.90M

1.5%

+4.61K

+0.16%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

VanEck Pharmaceutical ETF

5.16%

AdvisorShares Focused Equity ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.79%

VictoryShares US Multi-Factor Minimum Vol ETF

3.67%

Amplify Cash Flow Dividend Leaders ETF

3.56%

Indexperts Quality Earnings Focused ETF

3.04%

VanEck Retail ETF

2.81%

First Trust Consumer Staples Alphadex Fund

2.78%

Amplify Cash Flow High Income ETF

2.74%

Counterpoint Quantitative Equity ETF

2.37%

VanEck Pharmaceutical ETF

Proportion5.16%

AdvisorShares Focused Equity ETF

Proportion4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

Proportion3.79%

VictoryShares US Multi-Factor Minimum Vol ETF

Proportion3.67%

Amplify Cash Flow Dividend Leaders ETF

Proportion3.56%

Indexperts Quality Earnings Focused ETF

Proportion3.04%

VanEck Retail ETF

Proportion2.81%

First Trust Consumer Staples Alphadex Fund

Proportion2.78%

Amplify Cash Flow High Income ETF

Proportion2.74%

Counterpoint Quantitative Equity ETF

Proportion2.37%

Dividend

A total of 1.92B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Feb 05, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 03, 2025

Feb 14, 2025

Nov 06, 2024

COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

Jul 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024

Aug 09, 2024

Aug 26, 2024

Aug 09, 2024

May 01, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024

May 10, 2024

May 24, 2024

May 09, 2024

Jan 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024

Feb 09, 2024

Feb 26, 2024

Feb 08, 2024

Nov 02, 2023

COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Nov 27, 2023

Nov 10, 2023

Aug 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023

Aug 11, 2023

Aug 28, 2023

Aug 10, 2023

May 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023

May 12, 2023

May 30, 2023

May 11, 2023

Feb 01, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023

Feb 10, 2023

Feb 27, 2023

Feb 09, 2023

Nov 04, 2022

COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

286.930USD

Cencora Inc

286.930

Overview

Company